Skip to main content

Prodesse Licenses LUX from Invitrogen

NEW YORK, July 21 (GenomeWeb News) - Prodesse licensed the LUX technology from Invitrogen to develop its first diagnostic assays, Invitrogen said today.


The technology would allow Prodesse to provide customers with state-of-the-art molecular diagnostic products, Invitrogen said. Invitrogen gains a new customer base and enters new market segments, under the agreement.


According to the company, LUX, combined with SuperScript III Reverse Transcriptase and Platinum Tfi DNA Polymerase LUX offers a complete platform for assay development.



The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.